“The outlook revision reflects our anticipation that HMH will maintain the operating improvements of the first 10 months of fiscal 2015 and unrestricted reserves of no less than 100 days’ cash,” said Brian Williamson, an S&P credit analyst.
S&P also affirmed the underlying “BBB” rating on the hospital’s $38.84 million of series 2013 revenue bonds.
More articles on healthcare finance:
Medical companies paid physicians, teaching hospitals $6.49B in 2014
IRS provides clarification on hospital financial assistance policy requirements
CHI revenue increases while operating loss grows to $66.7M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
